MCT formulations for improving cognitive functions
AssigneesSociete des Produits Nestle S.A., Socpra Sciences Sante Et Humaines S.E.C.
InventorsBernard Cuenoud, Stephen Cosgrave Cunnane
Life of this patent
Estimating the term…
Loading patent…
AssigneesSociete des Produits Nestle S.A., Socpra Sciences Sante Et Humaines S.E.C.
InventorsBernard Cuenoud, Stephen Cosgrave Cunnane
Estimating the term…
Methods improve cognitive functioning, for example, at least one of episodic memory, executive function, or language skills; supporting memory and/or recall; providing energy and/or ketones to the brain; and/or preventing and/or treating mild cognitive impairment (MCI) in an individual. A composition comprising medium chain triglycerides (MCTs) can be administered to the individual in a daily dosage providing from about 15 g to about 45 g MCTs. The MCTs can include from about 51 wt % to about 90 wt % of octanoic acid. The daily dose can be provided in at least two servings, for example, 2 or 3 servings. Each serving can provide about 15 g MCTs and can include octanoic acid and decanoic acid in a weight ratio of, for example, about 60:about 40. The individual can be 65 years or older and/or have mild cognitive impairment (MCI).
A method of improving cognitive functioning comprising at least one of episodic memory, executive function, or language skills of an individual, the method comprising administering to the individual a composition comprising medium chain triglycerides (MCTs) in a daily dosage from about 15 g to about 45 g MCTs, wherein the MCTs comprise octanoic acid and decanoic acid in a weight ratio of 60:40, wherein the composition is in the form of a solid powder, further comprises at least one of pyridoxine (vitamin B6), folic acid (vitamin B9), or cobalamin (vitamin B12), and wherein the daily dosage comprises at least two servings of the composition, each serving comprising about 15 g MCTs.
A method of supporting memory and/or recall in an individual, the method comprising administering to the individual a composition comprising medium chain triglycerides (MCTs) in a daily dosage from about 15 g to about 45 g MCTs, wherein the MCTs comprise octanoic acid and decanoic acid in a weight ratio of 60:40, wherein the composition is in the form of a solid powder, further comprises at least one of pyridoxine (vitamin B6), folic acid (vitamin B9), or cobalamin (vitamin B12), and wherein the daily dosage comprises at least two servings of the composition, each serving comprising about 15 g MCTs.
A method of preventing and/or treating mild cognitive impairment (MCI), the method comprising administering to the individual a composition comprising medium chain triglycerides (MCTs) in a daily dosage from about 15 g to about 45 g MCTs, wherein the MCTs comprise octanoic acid and decanoic acid in a weight ratio of 60:40, wherein the composition is in the form of a solid powder, further comprises at least one of pyridoxine (vitamin B6), folic acid (vitamin B9), or cobalamin (vitamin B12), and wherein the daily dosage comprises at least two servings of the composition, each serving comprising about 15 g MCTs.
The method of claim, 1 wherein the daily dosage comprises three servings of the composition, each serving comprising about 15 g MCTs.
Dependencies are inferred from the claim text.